An innovative new therapy developed by a team in Belfast could potentially improve mobility for millions of patients with spinal cord injuries worldwide.
The treatment, pioneered by Belfast-based NeuroSolv Therapeutics, could potentially be administered to patients years after their initial injury.
Perineline, which received Orphan Drug Designation in 2022, has been developed as a result of research by highly-regarded neuro-/glyco-scientist Dr Jessica Kwok.
She has been working alongside a Belfast team led by Aidan and Ros Lynch, joint founders of NeuroSolv.
